ProtoKinetix, Incorporated (OTCMKTS:PKTX) Sees Large Increase in Short Interest

ProtoKinetix, Incorporated (OTCMKTS:PKTX) was the target of a significant growth in short interest in January. As of January 31st, there was short interest totalling 10,000 shares, a growth of 40.8% from the January 15th total of 7,100 shares. Based on an average daily trading volume, of 347,300 shares, the days-to-cover ratio is currently 0.0 days.

ProtoKinetix Stock Up 6.8 %

OTCMKTS:PKTX traded up $0.00 on Friday, reaching $0.01. 949,666 shares of the company’s stock were exchanged, compared to its average volume of 168,530. ProtoKinetix has a 52-week low of $0.01 and a 52-week high of $0.02. The business has a fifty day moving average of $0.01 and a 200-day moving average of $0.01.

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.